Profile - To The Moon

QueenSW

Posts · 53Posts · 53
Following · 0Following · 0
Followers · 0Followers · 0

- QueenSWQueenSW
  ·11-16
  $Tesla Motors(TSLA)$
  74 Comment
  Like
  Share
  Report
- QueenSWQueenSW
  ·11-13
  $Tesla Motors(TSLA)$
  16 Comment
  Like
  Share
  Report
- QueenSWQueenSW
  ·10-16
  $NVIDIA Corp(NVDA)$ buy
  148 Comment
  Like
  Share
  Report
- QueenSWQueenSW
  ·10-10
  $Tesla Motors(TSLA)$
  78 Comment
  Like
  Share
  Report
- QueenSWQueenSW
  ·09-26
  Life turner
  39 Comment
  Like
  Share
  Report
- QueenSWQueenSW
  ·2023-10-19
  $Lululemon Athletica(LULU)$ bull bull
  371 Comment
  Like
  Share
  Report
- QueenSWQueenSW
  ·2023-10-19
  $NVIDIA Corp(NVDA)$
  475 Comment
  Like
  Share
  Report
- QueenSWQueenSW
  ·2023-08-08
  AI, the future of tomorrow. Let's see how Recursion goes from here.
  Nvidia Just Confirmed an Emerging AI Boom in Biotech
  It takes about $900 million and 13.5 years to develop a new successful drug; but not for long. AI is turning that entire process on its head.
  Nvidia Just Confirmed an Emerging AI Boom in Biotech
  151 Comment
  Like
  Share
  Report
- QueenSWQueenSW
  ·2023-08-03
  $NIO Inc.(NIO)$ I'm still waiting for $21
  161 Comment
  1
  Share
  Report
- QueenSWQueenSW
  ·2023-07-29
  Fantastic!!! Finally. A long awaited. Can we see 150 before mid Aug?
  Roku Delivers A Beat For The Ages, This Rally Is For Real
  SummaryRoku stock surged 25% on Friday after releasing strong earnings.The company handily beat guidance as the ad recovery is underway.The company has a $1.8 billion net cash balance sheet position.T
  Roku Delivers A Beat For The Ages, This Rally Is For Real
  291 Comment
  Like
  Share
  Report
No following yet

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"4103671026890570","uuid":"4103671026890570","gmtCreate":1640567959580,"gmtModify":1660359384658,"name":"QueenSW","pinyin":"queensw","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/aa7c7803f7160b36b43cdc1267474765","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":8,"tweetSize":53,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"init","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.09.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.26","exceedPercentage":"93.92%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.01","exceedPercentage":"93.54%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.19","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.13","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":6,"crmLevelSwitch":1,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":371409602863608,"gmtCreate":1731716225297,"gmtModify":1731716227920,"author":{"id":"4103671026890570","authorId":"4103671026890570","name":"QueenSW","avatar":"https://community-static.tradeup.com/news/aa7c7803f7160b36b43cdc1267474765","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4103671026890570","authorIdStr":"4103671026890570"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$&nbsp;</a>&nbsp;","text":"$Tesla Motors(TSLA)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/371409602863608","isVote":1,"tweetType":1,"viewCount":74,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":370536203383008,"gmtCreate":1731465022321,"gmtModify":1731465023311,"author":{"id":"4103671026890570","authorId":"4103671026890570","name":"QueenSW","avatar":"https://community-static.tradeup.com/news/aa7c7803f7160b36b43cdc1267474765","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4103671026890570","authorIdStr":"4103671026890570"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","listText":"<a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","text":"$Tesla Motors(TSLA)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/370536203383008","isVote":1,"tweetType":1,"viewCount":16,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":360618924613840,"gmtCreate":1729060928818,"gmtModify":1729060932085,"author":{"id":"4103671026890570","authorId":"4103671026890570","name":"QueenSW","avatar":"https://community-static.tradeup.com/news/aa7c7803f7160b36b43cdc1267474765","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4103671026890570","authorIdStr":"4103671026890570"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA Corp(NVDA)$&nbsp;</a> buy","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA Corp(NVDA)$&nbsp;</a> buy","text":"$NVIDIA Corp(NVDA)$ buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/360618924613840","isVote":1,"tweetType":1,"viewCount":148,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":358522748821616,"gmtCreate":1728570852904,"gmtModify":1728570855480,"author":{"id":"4103671026890570","authorId":"4103671026890570","name":"QueenSW","avatar":"https://community-static.tradeup.com/news/aa7c7803f7160b36b43cdc1267474765","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4103671026890570","authorIdStr":"4103671026890570"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","listText":"<a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","text":"$Tesla Motors(TSLA)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/358522748821616","isVote":1,"tweetType":1,"viewCount":78,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":353595919933488,"gmtCreate":1727365227098,"gmtModify":1727365232885,"author":{"id":"4103671026890570","authorId":"4103671026890570","name":"QueenSW","avatar":"https://community-static.tradeup.com/news/aa7c7803f7160b36b43cdc1267474765","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4103671026890570","authorIdStr":"4103671026890570"},"themes":[],"htmlText":"Life turner","listText":"Life turner","text":"Life turner","images":[{"img":"https://community-static.tradeup.com/news/2704bd0a362d350bcbd5f59d23afc6bc","width":"728","height":"1480"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/353595919933488","isVote":1,"tweetType":1,"viewCount":39,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":231995505135704,"gmtCreate":1697669653875,"gmtModify":1697669656890,"author":{"id":"4103671026890570","authorId":"4103671026890570","name":"QueenSW","avatar":"https://community-static.tradeup.com/news/aa7c7803f7160b36b43cdc1267474765","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4103671026890570","authorIdStr":"4103671026890570"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/LULU\">$Lululemon Athletica(LULU)$ &nbsp;</a>bull bull","listText":"<a href=\"https://ttm.financial/S/LULU\">$Lululemon Athletica(LULU)$ &nbsp;</a>bull bull","text":"$Lululemon Athletica(LULU)$ bull bull","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/231995505135704","isVote":1,"tweetType":1,"viewCount":371,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":231996089884936,"gmtCreate":1697669627822,"gmtModify":1697669629460,"author":{"id":"4103671026890570","authorId":"4103671026890570","name":"QueenSW","avatar":"https://community-static.tradeup.com/news/aa7c7803f7160b36b43cdc1267474765","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4103671026890570","authorIdStr":"4103671026890570"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA Corp(NVDA)$&nbsp;</a><v-v data-views=\"1\"></v-v>","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA Corp(NVDA)$&nbsp;</a><v-v data-views=\"1\"></v-v>","text":"$NVIDIA Corp(NVDA)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/231996089884936","isVote":1,"tweetType":1,"viewCount":475,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":206522881441936,"gmtCreate":1691452356159,"gmtModify":1691452359599,"author":{"id":"4103671026890570","authorId":"4103671026890570","name":"QueenSW","avatar":"https://community-static.tradeup.com/news/aa7c7803f7160b36b43cdc1267474765","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4103671026890570","authorIdStr":"4103671026890570"},"themes":[],"htmlText":"AI, the future of tomorrow. Let's see how Recursion goes from here.","listText":"AI, the future of tomorrow. Let's see how Recursion goes from here.","text":"AI, the future of tomorrow. Let's see how Recursion goes from here.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/206522881441936","repostId":"2357588012","repostType":2,"repost":{"id":"2357588012","kind":"highlight","pubTimestamp":1691418943,"share":"https://ttm.financial/m/news/2357588012?lang=&edition=fundamental","pubTime":"2023-08-07 22:35","market":"us","language":"en","title":"Nvidia Just Confirmed an Emerging AI Boom in Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2357588012","media":"InvestorPlace","summary":"It takes about $900 million and 13.5 years to develop a new successful drug; but not for long. AI is turning that entire process on its head.","content":"<html><body><div>\n<div>\n<ul><li>Trillion-dollar AI chipmaker Nvidia recently announced a huge new partnership with biotech AI startup Recursion Pharmaceuticals.</li><li>AI’s application in the field of biology holds the potential to unlock enormous economic value for one simple reason: data.</li><li>The drug discovery and development process is prohibitively long and expensive, but AI can significantly shorten and cheapen this process. It can map out human genetic data, identify mutations, and run simulations of compounds to fight those mutations – all in an instant.</li><li>Earlier this year, Japanese pharma giant Takeda Pharmaceutical bought an experimental psoriasis drug for $4 billion – a drug that was created in only six months by using AI. And it isn’t alone.</li></ul> </div>\n<div></div>\n<figure>\n<div>\n<img decoding=\"async\" height=\"432\" sizes=\"(max-width: 768px) 100vw, 768px\" src=\"https://investorplace.com/wp-content/uploads/2023/05/artificial-intelligence-brain-network-ai-stocks-1600-768x432.jpg\" srcset=\"https://investorplace.com/wp-content/uploads/2023/05/artificial-intelligence-brain-network-ai-stocks-1600-768x432.jpg 768w, https://investorplace.com/wp-content/uploads/2023/05/artificial-intelligence-brain-network-ai-stocks-1600-300x169.jpg 300w, https://investorplace.com/wp-content/uploads/2023/05/artificial-intelligence-brain-network-ai-stocks-1600-1024x576.jpg 1024w, https://investorplace.com/wp-content/uploads/2023/05/artificial-intelligence-brain-network-ai-stocks-1600-1536x864.jpg 1536w, https://investorplace.com/wp-content/uploads/2023/05/artificial-intelligence-brain-network-ai-stocks-1600-200x113.jpg 200w, https://investorplace.com/wp-content/uploads/2023/05/artificial-intelligence-brain-network-ai-stocks-1600-400x225.jpg 400w, https://investorplace.com/wp-content/uploads/2023/05/artificial-intelligence-brain-network-ai-stocks-1600-116x65.jpg 116w, https://investorplace.com/wp-content/uploads/2023/05/artificial-intelligence-brain-network-ai-stocks-1600-100x56.jpg 100w, https://investorplace.com/wp-content/uploads/2023/05/artificial-intelligence-brain-network-ai-stocks-1600-89x50.jpg 89w, https://investorplace.com/wp-content/uploads/2023/05/artificial-intelligence-brain-network-ai-stocks-1600-78x44.jpg 78w, https://investorplace.com/wp-content/uploads/2023/05/artificial-intelligence-brain-network-ai-stocks-1600.jpg 1600w\" width=\"768\"/> </div>\n<figcaption>\n<p>Source: shutterstock.com/cono0430</p>\n</figcaption>\n</figure>\n<div>\n<p><i>Editor’s note: “Nvidia Just Confirmed an Emerging AI Boom in Biotech</i><i>” was previously published in </i><i>July 2023</i><i>. It has since been updated to include the most relevant information available.</i></p>\n<p>We’ve long said that artificial intelligence (<span>AI</span>) will have the most profound economic impact in the medical industry, where it can be used to accelerate and cheapen everything from drug discovery to patient treatment.</p>\n<p>And <strong>Nvidia</strong> (<strong><span><strong><u>NVDA</u></strong></span></strong>), the world’s preeminent AI company, may have just confirmed that sentiment last month.</p>\n<p>The trillion-dollar AI chipmaker announced a huge new partnership with biotech AI startup <strong>Recursion Pharmaceuticals</strong> (<strong><span><strong><u>RXRX</u></strong></span></strong>), which has developed a novel AI-driven platform for drug development and discovery.</p>\n<p>Recursion will train its AI models on Nvidia’s cloud platform, which Nvidia will then license through its newly announced BioNeMo generative AI cloud service for drug discovery.</p>\n<p>Nvidia will also pour $50 million into Recursion in exchange for a ~4% stake in the company.</p>\n<p>This is a massive deal. Look no further than how much RXRX stock rallied before and after the deal was announced.</p>\n<p><img decoding=\"async\" height=\"580\" loading=\"lazy\" sizes=\"(max-width: 930px) 100vw, 930px\" src=\"https://investorplace.com/wp-content/uploads/2023/07/rxrx-graph-080723.png\" srcset=\"https://investorplace.com/wp-content/uploads/2023/07/rxrx-graph-080723.png 930w, https://investorplace.com/wp-content/uploads/2023/07/rxrx-graph-080723-300x187.png 300w, https://investorplace.com/wp-content/uploads/2023/07/rxrx-graph-080723-768x479.png 768w, https://investorplace.com/wp-content/uploads/2023/07/rxrx-graph-080723-200x125.png 200w, https://investorplace.com/wp-content/uploads/2023/07/rxrx-graph-080723-400x249.png 400w, https://investorplace.com/wp-content/uploads/2023/07/rxrx-graph-080723-116x72.png 116w, https://investorplace.com/wp-content/uploads/2023/07/rxrx-graph-080723-100x62.png 100w, https://investorplace.com/wp-content/uploads/2023/07/rxrx-graph-080723-80x50.png 80w, https://investorplace.com/wp-content/uploads/2023/07/rxrx-graph-080723-78x49.png 78w\" width=\"930\"/><noscript><img decoding=\"async\" height=\"580\" loading=\"lazy\" sizes=\"(max-width: 930px) 100vw, 930px\" src=\"https://investorplace.com/wp-content/uploads/2023/07/rxrx-graph-080723.png\" srcset=\"https://investorplace.com/wp-content/uploads/2023/07/rxrx-graph-080723.png 930w, https://investorplace.com/wp-content/uploads/2023/07/rxrx-graph-080723-300x187.png 300w, https://investorplace.com/wp-content/uploads/2023/07/rxrx-graph-080723-768x479.png 768w, https://investorplace.com/wp-content/uploads/2023/07/rxrx-graph-080723-200x125.png 200w, https://investorplace.com/wp-content/uploads/2023/07/rxrx-graph-080723-400x249.png 400w, https://investorplace.com/wp-content/uploads/2023/07/rxrx-graph-080723-116x72.png 116w, https://investorplace.com/wp-content/uploads/2023/07/rxrx-graph-080723-100x62.png 100w, https://investorplace.com/wp-content/uploads/2023/07/rxrx-graph-080723-80x50.png 80w, https://investorplace.com/wp-content/uploads/2023/07/rxrx-graph-080723-78x49.png 78w\" width=\"930\"/></noscript></p>\n<p><strong><em><u>But this is likely just the start of the big boom at the convergence of AI and medicine. </u></em></strong></p>\n<p>Nvidia is a trillion-dollar juggernaut in the world of AI. It could’ve chosen any industry to commit its money and resources to. And of all industries, it chose biotechnology.</p>\n<p>Why?</p>\n<p><strong>Data.</strong></p>\n<div>\n<div>\n<div></div>\n<div></div>\n</div>\n</div>\n<h2>In a World of Data, Today’s AI Is Just the Beginning</h2>\n<p><span>Like computers, humans are nothing more than a bunch of data strung together. </span></p>\n<p><span>At their core, computers are just a bunch of 1s and 0s coded in sequence, with each number corresponding to a certain action for the computer to perform. Human DNA is much the same. We’re just a bunch of As, Gs, Cs, and Ts strung together. Those are the four base types found in human DNA molecules, each determining a person’s characteristics, traits, and even actions. </span></p>\n<p><img decoding=\"async\" height=\"435\" loading=\"lazy\" sizes=\"(max-width: 1165px) 100vw, 1165px\" src=\"https://investorplace.com/wp-content/uploads/2023/05/chromosome-dna-gcats.png\" srcset=\"https://investorplace.com/wp-content/uploads/2023/05/chromosome-dna-gcats.png 1165w, https://investorplace.com/wp-content/uploads/2023/05/chromosome-dna-gcats-300x112.png 300w, https://investorplace.com/wp-content/uploads/2023/05/chromosome-dna-gcats-1024x382.png 1024w, https://investorplace.com/wp-content/uploads/2023/05/chromosome-dna-gcats-768x287.png 768w, https://investorplace.com/wp-content/uploads/2023/05/chromosome-dna-gcats-200x75.png 200w, https://investorplace.com/wp-content/uploads/2023/05/chromosome-dna-gcats-400x149.png 400w, https://investorplace.com/wp-content/uploads/2023/05/chromosome-dna-gcats-116x43.png 116w, https://investorplace.com/wp-content/uploads/2023/05/chromosome-dna-gcats-100x37.png 100w, https://investorplace.com/wp-content/uploads/2023/05/chromosome-dna-gcats-134x50.png 134w, https://investorplace.com/wp-content/uploads/2023/05/chromosome-dna-gcats-78x29.png 78w\" width=\"1165\"/><noscript><img decoding=\"async\" height=\"435\" loading=\"lazy\" sizes=\"(max-width: 1165px) 100vw, 1165px\" src=\"https://investorplace.com/wp-content/uploads/2023/05/chromosome-dna-gcats.png\" srcset=\"https://investorplace.com/wp-content/uploads/2023/05/chromosome-dna-gcats.png 1165w, https://investorplace.com/wp-content/uploads/2023/05/chromosome-dna-gcats-300x112.png 300w, https://investorplace.com/wp-content/uploads/2023/05/chromosome-dna-gcats-1024x382.png 1024w, https://investorplace.com/wp-content/uploads/2023/05/chromosome-dna-gcats-768x287.png 768w, https://investorplace.com/wp-content/uploads/2023/05/chromosome-dna-gcats-200x75.png 200w, https://investorplace.com/wp-content/uploads/2023/05/chromosome-dna-gcats-400x149.png 400w, https://investorplace.com/wp-content/uploads/2023/05/chromosome-dna-gcats-116x43.png 116w, https://investorplace.com/wp-content/uploads/2023/05/chromosome-dna-gcats-100x37.png 100w, https://investorplace.com/wp-content/uploads/2023/05/chromosome-dna-gcats-134x50.png 134w, https://investorplace.com/wp-content/uploads/2023/05/chromosome-dna-gcats-78x29.png 78w\" width=\"1165\"/></noscript></p>\n<p><span>Essentially, the connecting element here is data. </span></p>\n<p><span>That means AI can have an</span> <b><i>especially profound impact on the human body.</i></b><b><i> </i></b></p>\n<p><span>After all, at the end of the day, what is AI? It is just a machine learning algorithm processing tons of data to learn how to perform a certain task or variety of tasks. It’s all just algorithms and data, with data acting as the model’s “fuel.”</span></p>\n<p><span>The quantity and quality of data an AI model has access to determines the quality of the model itself. </span></p>\n<p><span>When it comes to the human body, there is no dearth of quality data. As mentioned above, we are nothing more than a bunch of quality genetic data strung together.</span></p>\n<p><b>Apply AI to all that data, and you will change the world. </b></p>\n<p><span>Seriously. </span></p>\n<p>Consider the value proposition of Recursion’s core AI technology.</p>\n<p>Currently, it takes about $900 million and 13.5 years to develop a new successful drug. With AI constantly running simulations, drug development could happen in months and for less than $100 million.</p>\n<p>That may sound hard to believe, but it’s true. <em>Drugs are already being discovered by AI that quickly. </em></p>\n<h2>AI Meets Biotech</h2>\n<p><span>Earlier this year, Japanese pharma giant </span><b>Takeda Pharmaceutical</b><span> bought an experimental psoriasis drug for $4 billion – a drug that was created in only six months by using artificial intelligence. </span></p>\n<p><span>And it isn’t alone. </span></p>\n<p><span>Other pharma giants like </span><b>Bayer </b><span>(</span><b><span><strong><u>BAYRY</u></strong></span></b><span>), </span><b>Roche </b><span>(</span><b><span><strong><u>RHHBY</u></strong></span></b><span>), </span><b><a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a> </b><span>(</span><b><span><strong><u>SNY</u></strong></span></b><span>), and </span><b>AstraZeneca </b><span>(</span><b><span><strong><u>AZN</u></strong></span></b><span>) are actively using AI technology for drug discovery purposes. </span></p>\n<p><span>The future of drug discovery starts now. </span></p>\n<p><b>This is big business.</b><b> </b></p>\n<p><span>Research firm Deep Pharma Intelligence estimates that investments in the field of AI-powered drug discovery have tripled over the past four years to nearly $25 billion. Morgan Stanley believes that AI-powered drug discovery will lead to an additional 50 novel therapies being brought to market over the next decade, with annual sales in excess of $50 billion!</span></p>\n<div><img height=\"594\" loading=\"lazy\" src=\"https://investorplace.com/wp-content/uploads/2023/05/investment-in-ai-drug-development.png\" width=\"1174\"/><div>Source: Deep Pharma Intelligence</div></div>\n<p><span>In other words, a $50 billion drug discovery revolution starts now. </span></p>\n<p><span>Is your portfolio positioned for it?</span></p>\n<div>\n<div>\n<div></div>\n<div></div>\n</div>\n</div>\n<h2>The Final Word</h2>\n<p>If not, <span>I want to tell you about one of my favorite investments for this new bull market. </span></p>\n<p><b>One great prospective investment is the very company that started this whole stock boom –</b> <b>OpenAI, the creator of ChatGPT.</b><b> </b></p>\n<p><span>Since ChatGPT’s launch in November 2022, the company’s valuation has doubled!</span></p>\n<p><span>But that’s just the start. </span></p>\n<p><span>I truly believe OpenAI could be one of the world’s largest companies in the near future – if not </span><i><span>the </span></i><span>largest. </span></p>\n<p><b>OpenAI represents the potential investment opportunity of a lifetime. </b></p>\n<p><span>Too bad it is a startup that you can’t buy on a public exchange like a big stock… </span></p>\n<p><span>Though I did manage to unearth an investment ‘loophole’ that allows you to take a stake in OpenAI now – </span><i><span>before </span></i><span>its highly anticipated IPO. </span></p>\n<p><span>This is your chance to invest in the next big thing. Like investing in </span><b>Apple </b><span>(</span><b><span><strong><u>AAPL</u></strong></span></b><span>) in the 1980s or </span><b>Amazon </b><span>(</span><b><span><strong><u>AMZN</u></strong></span></b><span>) in the 1990s, this is an opportunity you can’t afford to miss. </span></p>\n<p><b>Learn all about it.</b></p>\n<p><em>On the date of publication, Luke Lango did not have (either directly or indirectly) any positions in the securities mentioned in this article.</em></p>\n<div>\n<div>\n<div></div>\n<div></div>\n</div>\n</div>\n</div>\n<div>\n<div hidden=\"true\">\n<div>\n<svg fill=\"none\" height=\"32\" viewbox=\"0 0 261 32\" width=\"261\" xmlns=\"http://www.w3.org/2000/svg\">\n<path d=\"M38.8652 7.49652H42.2492V25.7517H38.8652V7.49652ZM60.0112 7.49652H63.3142V25.7517H60.0921L50.9278 13.1733V25.7517H47.6248V7.49652H50.8469L60.0112 20.0749V7.49652ZM66.5201 7.49652H70.2279L75.4578 21.8955L80.7685 7.49652H84.3144L77.1417 25.7517H73.5957L66.5201 7.49652ZM87.4232 7.49652H100.457V10.5418H90.8072V15.0601H99.5019V18.1054H90.8072V22.7064H100.781V25.7517H87.4232V7.49652ZM113.637 10.8563C112.666 10.5253 111.872 10.3598 111.063 10.3598C110.253 10.3598 109.622 10.5253 109.136 10.8563C108.65 11.1873 108.407 11.601 108.407 12.1803C108.407 12.6768 108.569 13.0906 108.893 13.4216C109.217 13.7526 109.622 14.0009 110.188 14.2491C110.674 14.4974 111.403 14.7456 112.196 14.9939C113.41 15.3249 114.366 15.7387 115.175 16.0697C115.985 16.4007 116.616 16.98 117.183 17.7082C117.75 18.453 117.993 19.3467 117.993 20.5052C117.993 21.6638 117.669 22.5575 117.102 23.385C116.535 24.2125 115.742 24.858 114.689 25.2718C113.637 25.6855 112.52 25.9338 111.144 25.9338C109.767 25.9338 108.407 25.6855 107.047 25.1063C105.752 24.6098 104.554 23.865 103.582 22.9713L105.023 20.0087C105.914 20.8362 106.95 21.4817 108.083 21.9782C109.217 22.4747 110.253 22.723 111.225 22.723C112.196 22.723 112.908 22.5575 113.475 22.1437C114.042 21.73 114.285 21.2334 114.285 20.588C114.285 20.0915 114.123 19.5949 113.799 19.2639C113.475 18.9329 113.07 18.6847 112.504 18.4364C112.018 18.1882 111.289 18.0226 110.415 17.6916C109.201 17.3606 108.245 16.9469 107.436 16.6159C106.626 16.2848 105.995 15.7056 105.509 15.0601C104.942 14.3153 104.699 13.4216 104.699 12.2631C104.699 11.1873 104.942 10.2936 105.509 9.46603C106.076 8.6385 106.869 8.07578 107.841 7.66202C108.893 7.24826 110.01 7 111.386 7C112.52 7 113.718 7.16551 114.851 7.49652C115.985 7.82753 117.021 8.32404 117.912 8.88676L116.471 12.1803C115.499 11.6838 114.609 11.27 113.637 10.8563ZM120.146 7.49652H134.702V10.6246H129.148V25.7517H125.683V10.608H120.13V7.49652H120.146ZM149.987 8.473C151.428 9.30052 152.561 10.4425 153.452 11.8493C154.261 13.2395 154.747 14.8946 154.747 16.6159C154.747 18.3371 154.342 19.9094 153.452 21.3824C152.642 22.7726 151.444 23.9312 149.987 24.7587C148.546 25.5862 146.926 26 145.162 26C143.397 26 141.778 25.5862 140.337 24.7587C138.896 23.9312 137.762 22.7892 136.872 21.3824C136.062 19.9922 135.576 18.3371 135.576 16.6159C135.576 14.8946 135.981 13.3223 136.872 11.8493C137.681 10.4591 138.879 9.30052 140.337 8.473C141.794 7.64547 143.397 7.23171 145.162 7.23171C146.926 7.23171 148.546 7.66202 149.987 8.473ZM142.182 11.1873C141.211 11.7666 140.499 12.5113 139.932 13.4051C139.365 14.3981 139.122 15.3746 139.122 16.5331C139.122 17.6916 139.365 18.7509 139.932 19.6611C140.499 20.6542 141.227 21.3824 142.182 21.9617C143.073 22.5409 144.109 22.7892 145.243 22.7892C146.295 22.7892 147.331 22.5409 148.222 21.9617C149.112 21.3824 149.825 20.6376 150.391 19.6611C150.958 18.6681 151.201 17.6916 151.201 16.5331C151.201 15.3746 150.958 14.3153 150.391 13.4051C149.825 12.4948 149.096 11.6838 148.222 11.1873C147.331 10.608 146.295 10.3598 145.243 10.3598C144.109 10.3763 143.073 10.608 142.182 11.1873ZM169.773 25.7517L166.712 20.3232H162.049V25.669H158.665V7.49652H166.065C168.396 7.49652 170.161 8.07578 171.456 9.13502C172.752 10.2108 173.302 11.7666 173.302 13.7361C173.302 15.1263 172.978 16.3676 172.412 17.3606C171.764 18.3537 170.971 19.0819 169.756 19.6611L173.691 25.669H169.756L169.773 25.7517ZM161.968 17.2779H165.984C167.279 17.2779 168.234 17.0296 168.963 16.4503C169.611 15.8711 170.015 15.0601 170.015 13.9016C170.015 12.743 169.692 11.9321 168.963 11.4355C168.315 10.8563 167.279 10.608 165.984 10.608H161.968V17.2779ZM190.757 8.90331C191.971 9.97909 192.521 11.4521 192.521 13.3389C192.521 15.3084 191.874 16.8807 190.757 17.9399C189.542 19.0157 187.858 19.5784 185.608 19.5784H180.783V25.5035H179.018V7.34756H185.608C187.777 7.34756 189.542 7.92683 190.757 8.90331ZM189.461 16.8807C190.352 16.0531 190.821 14.9939 190.821 13.4216C190.821 11.9486 190.336 10.8728 189.461 10.0453C188.571 9.21777 187.211 8.88676 185.527 8.88676H180.783V18.0226H185.527C187.211 18.0392 188.506 17.7082 189.461 16.8807ZM197.023 7.34756H198.787V23.9643H206.673V25.6028H197.104V7.34756H197.023ZM224.516 25.6028L222.427 20.7535H212.534L210.445 25.6028H208.599L216.647 7.43031H218.492L226.54 25.6028H224.516ZM213.182 19.115H221.714L217.456 9.25087L213.182 19.115ZM240.286 9.39983C239.315 8.98606 238.359 8.82056 237.388 8.82056C236.028 8.82056 234.732 9.15157 233.599 9.81359C232.466 10.4756 231.51 11.3693 230.863 12.6106C230.215 13.7692 229.81 15.0767 229.81 16.4835C229.81 17.8737 230.134 19.115 230.863 20.3563C231.51 21.5148 232.466 22.4085 233.599 23.1533C234.732 23.8153 236.011 24.2291 237.388 24.2291C238.359 24.2291 239.315 24.0636 240.286 23.6498C241.257 23.2361 242.051 22.7395 242.779 22.0113L243.832 23.1699C242.941 23.9974 241.905 24.6429 240.772 25.1394C239.638 25.6359 238.44 25.8841 237.307 25.8841C235.623 25.8841 234.085 25.4704 232.644 24.6429C231.203 23.8153 230.15 22.6733 229.26 21.2666C228.45 19.8763 228.045 18.304 228.045 16.5828C228.045 14.8615 228.45 13.372 229.341 11.9817C230.15 10.5915 231.267 9.43293 232.725 8.6054C234.166 7.77788 235.704 7.36411 237.388 7.36411C238.602 7.36411 239.719 7.61237 240.853 8.02613C241.986 8.52265 242.941 9.10192 243.832 9.91289L242.779 11.1376C242.051 10.3929 241.241 9.81359 240.286 9.39983ZM248.641 7.34756H260.541V8.98606H250.406V15.4904H259.489V17.1289H250.406V23.9477H260.865V25.5862H248.641V7.34756Z\" fill=\"#212121\"></path>\n<path d=\"M31.3505 14.3755C31.3667 14.6507 31.3829 15.1201 31.2857 15.1687C31.1077 15.1201 30.9458 13.5337 31.1077 13.4365H31.1239C31.2534 13.4689 31.3343 14.0355 31.3505 14.3755Z\" fill=\"#00A000\"></path>\n<path d=\"M16.959 13.1775C16.7485 15.4763 13.8346 16.3343 12.4424 14.505C11.3092 13.0156 12.1996 10.6036 14.4659 10.4902C16.3438 10.6036 17.0561 12.1253 16.959 13.1775Z\" fill=\"#00A000\"></path>\n<path d=\"M14.1103 18.034C14.0456 18.7949 13.4952 20.1223 11.8116 20.2195C9.41565 20.09 8.65479 17.176 10.1441 15.8C10.7269 15.282 11.3421 15.2496 11.6497 15.2334C13.4952 15.3305 14.2075 16.9332 14.1103 18.034Z\" fill=\"#00A000\"></path>\n<path d=\"M21.4764 15.9942C21.4116 16.7875 20.8288 18.1797 19.1128 18.2768C16.555 18.1473 15.9075 15.1686 17.5749 13.7602C18.1901 13.2422 18.8052 13.2098 19.1128 13.1936C21.0069 13.3069 21.5735 14.9743 21.4764 15.9942Z\" fill=\"#00A000\"></path>\n<path d=\"M18.7565 20.6727C18.4004 22.7773 15.6969 23.4248 14.4504 21.7088C13.4952 20.3975 14.1104 18.1311 16.4739 18.0178C18.3356 18.115 18.9184 19.6205 18.7565 20.6727Z\" fill=\"#00A000\"></path>\n<path d=\"M12.1507 10.555C12.0373 11.2349 11.4384 12.4005 9.98138 12.4976C7.90925 12.3843 7.89306 10.0046 9.1072 8.90376C9.68999 8.38572 10.2242 8.35335 10.4832 8.33716C11.9726 8.4181 12.2963 9.74556 12.1507 10.555Z\" fill=\"#00A000\"></path>\n<path d=\"M18.9993 8.758C19.0155 10.4578 16.8462 11.2187 15.5349 9.97214C14.3532 8.85513 14.9521 6.76681 16.8948 6.66968C18.4165 6.76681 18.9831 7.99714 18.9993 8.758Z\" fill=\"#00A000\"></path>\n<path d=\"M23.2892 11.2836C23.3864 13.0157 21.6056 13.8737 20.2458 12.7405C18.805 11.5264 19.2259 9.19524 20.9095 9.01717C20.9581 9.01717 21.039 9.01717 21.1038 9.00098C22.6093 9.09811 23.2407 10.4579 23.2892 11.2836Z\" fill=\"#00A000\"></path>\n<path d=\"M9.34996 15.1687C9.28521 15.8972 8.79955 17.1599 7.4559 17.2409C5.44853 17.1114 5.10857 14.2136 6.53316 13.0642C6.95406 12.7405 7.31021 12.7081 7.55304 12.6919C8.86431 12.7728 9.46328 14.0355 9.34996 15.1687Z\" fill=\"#00A000\"></path>\n<path d=\"M25.0365 18.6978C24.6642 20.608 22.6406 21.3203 21.7017 19.8634C20.8599 18.5521 21.6369 16.3343 23.4015 16.2209C24.8422 16.3181 25.2308 17.7265 25.0365 18.6978Z\" fill=\"#00A000\"></path>\n<path d=\"M11.6007 22.4698C11.633 23.9267 10.1437 24.7847 8.80003 23.603C7.47257 22.4212 7.7154 20.3976 9.22093 20.2196C9.2695 20.2196 9.35044 20.2196 9.4152 20.2034C10.7265 20.2843 11.5683 21.4337 11.6007 22.4698Z\" fill=\"#00A000\"></path>\n<path d=\"M15.8267 24.7199C15.7781 25.2218 15.341 26.1769 14.1269 26.2417C12.4433 26.1607 11.4882 24.1857 12.6052 23.1335C13.0585 22.7126 13.5765 22.6964 13.8031 22.6802C15.1953 22.7449 15.94 23.781 15.8267 24.7199Z\" fill=\"#00A000\"></path>\n<path d=\"M22.1549 23.101C21.6044 24.6713 19.5485 25.3835 18.7715 23.8942C18.1563 22.7286 19.0628 20.9641 20.7303 20.8669C21.8797 20.8831 22.5758 21.9354 22.1549 23.101Z\" fill=\"#00A000\"></path>\n<path d=\"M14.6774 6.50773C14.5965 7.00958 14.0946 7.9647 12.7995 8.02946C11.1807 7.93233 10.9702 6.31347 12.0225 5.32597C12.5567 4.82413 13.0747 4.80794 13.2852 4.79175C14.4184 4.8565 14.7907 5.82781 14.6774 6.50773Z\" fill=\"#00A000\"></path>\n<path d=\"M7.18189 19.9604C7.19808 20.1223 7.26284 21.5631 6.06488 21.6602C4.41365 21.5469 3.71755 18.8758 4.75361 18.0016C5.01263 17.7912 5.25546 17.775 5.41734 17.7588C6.53435 17.8397 7.11714 19.0862 7.18189 19.9604Z\" fill=\"#00A000\"></path>\n<path d=\"M26.9959 13.906C27.0282 15.4601 25.7655 16.3019 24.7457 15.4115C23.5477 14.3593 23.7096 11.8177 25.3123 11.7043C26.3645 11.7691 26.9635 12.8861 26.9959 13.906Z\" fill=\"#00A000\"></path>\n<path d=\"M18.9988 26.7921C18.9826 26.8407 18.5455 27.8929 17.3961 27.9577C16.182 27.8767 15.7611 26.436 16.7 25.5941C17.1695 25.1732 17.6551 25.1571 17.8656 25.1409C19.0635 25.2218 19.2416 26.1446 18.9988 26.7921Z\" fill=\"#00A000\"></path>\n<path d=\"M20.0999 4.92117C20.1808 5.32589 20.0837 6.11913 19.08 6.16769C17.6392 6.08675 16.9755 4.53265 17.7525 3.77179C18.0116 3.52896 18.303 3.51277 18.4325 3.49658C19.3228 3.56134 19.9704 4.37076 20.0999 4.92117Z\" fill=\"#00A000\"></path>\n<path d=\"M8.33073 8.11044C8.15266 8.61229 7.55368 9.55122 6.58237 9.61598C5.33585 9.51884 5.57868 7.80286 6.6795 6.86392C7.16515 6.44302 7.53749 6.42683 7.68319 6.41064C8.54118 6.4754 8.58975 7.44671 8.33073 8.11044Z\" fill=\"#00A000\"></path>\n<path d=\"M5.43276 12.449C5.30325 13.0317 4.86616 14.0516 3.97579 14.1164C2.6807 14.0031 2.8264 11.6557 3.89485 10.7492C4.20243 10.4901 4.42907 10.474 4.59095 10.4578C5.40038 10.5387 5.62702 11.5424 5.43276 12.449Z\" fill=\"#00A000\"></path>\n<path d=\"M24.1468 6.88001C24.5029 7.98083 23.6773 8.66075 22.6251 8.11034C21.4109 7.4628 21.0224 5.58493 22.0423 5.30972C22.107 5.29353 22.2042 5.29353 22.2689 5.27734C23.224 5.3421 23.9363 6.24866 24.1468 6.88001Z\" fill=\"#00A000\"></path>\n<path d=\"M10.0796 26.3387C10.0958 26.3873 10.4196 27.4395 9.5454 27.4881C8.34745 27.4233 7.08474 25.6264 7.78085 24.9789C7.94273 24.817 8.15318 24.8008 8.28269 24.8008C9.20544 24.8493 9.88536 25.7235 10.0796 26.3387Z\" fill=\"#00A000\"></path>\n<path d=\"M27.3692 21.3364C26.916 22.5991 25.5885 23.3438 25.1514 22.3077C24.7143 21.304 25.5237 19.4747 26.7055 19.3938C27.6283 19.4747 27.6444 20.5756 27.3692 21.3364Z\" fill=\"#00A000\"></path>\n<path d=\"M24.245 25.2864C23.5975 26.4034 22.2053 26.9862 21.9463 26.0311C21.7034 25.1569 22.6586 23.7323 23.7917 23.6514C24.6336 23.7161 24.6821 24.5579 24.245 25.2864Z\" fill=\"#00A000\"></path>\n<path d=\"M13.8031 28.1518C13.9003 29.0098 13.0909 29.4631 12.1519 28.7184C11.1644 27.9576 11.3101 26.9377 12.1519 26.8406C12.1843 26.8406 12.2329 26.8406 12.2814 26.8406C13.1394 26.873 13.7384 27.5529 13.8031 28.1518Z\" fill=\"#00A000\"></path>\n<path d=\"M16.4094 3.23778C16.3446 4.22528 14.9848 4.50049 14.4182 3.83676C13.9002 3.20541 14.4668 2.18553 15.3571 2.13696C16.0047 2.15315 16.4418 2.71975 16.4094 3.23778Z\" fill=\"#00A000\"></path>\n<path d=\"M11.3909 4.41948C10.8891 5.55268 9.52923 5.95739 9.18927 5.27747C8.8655 4.59756 9.95013 3.31866 10.9053 3.25391C11.5042 3.25391 11.6337 3.85288 11.3909 4.41948Z\" fill=\"#00A000\"></path>\n<path d=\"M3.3601 17.1921C3.37629 18.4063 2.74494 19.0862 2.12977 18.5034C1.32034 17.7264 1.30416 15.3466 2.34022 15.2495C3.06871 15.3305 3.34391 16.4798 3.3601 17.1921Z\" fill=\"#00A000\"></path>\n<path d=\"M27.6917 9.24369C27.9993 10.2798 27.4812 10.9435 26.688 10.5226C25.6519 9.97217 25.1177 7.91622 25.9433 7.64102C25.9919 7.62483 26.0728 7.62483 26.1214 7.60864C26.8984 7.6734 27.4974 8.59614 27.6917 9.24369Z\" fill=\"#00A000\"></path>\n<path d=\"M29.5543 16.6256C29.4409 17.9045 28.6153 18.6006 28.0649 17.8883C27.4012 17.0303 27.6764 14.8287 28.6801 14.7153C29.3924 14.7801 29.619 15.8809 29.5543 16.6256Z\" fill=\"#00A000\"></path>\n<path d=\"M6.01558 24.218C6.03177 24.2666 6.43648 25.3674 5.72419 25.4483C4.68812 25.3674 3.49017 23.3924 4.10533 22.7772C4.20246 22.6801 4.31578 22.6639 4.41292 22.6477C5.10902 22.6963 5.75656 23.4895 6.01558 24.218Z\" fill=\"#00A000\"></path>\n<path d=\"M16.5051 29.5441C16.2946 30.2887 15.2909 30.5154 14.87 29.706C14.611 29.2041 14.8862 28.6213 15.6633 28.5728C16.3432 28.6051 16.6346 29.0908 16.5051 29.5441Z\" fill=\"#00A000\"></path>\n<path d=\"M20.7967 28.4756C20.5538 28.7831 19.9711 29.2688 19.4206 29.285C18.7407 29.2364 18.9512 28.2813 19.6311 27.7147C20.0682 27.3424 20.4405 27.3262 20.57 27.3262C21.2176 27.3747 21.2176 27.9575 20.7967 28.4756Z\" fill=\"#00A000\"></path>\n<path d=\"M19.8739 2.15321C20.0682 2.41223 20.1815 2.81694 19.6797 2.84932C18.8217 2.80076 18.1741 1.7485 18.5141 1.48948C18.5626 1.44092 18.6274 1.44092 18.6922 1.44092C19.0969 1.45711 19.6311 1.82944 19.8739 2.15321Z\" fill=\"#00A000\"></path>\n<path d=\"M13.8509 1.66741C13.5433 2.29876 12.653 2.54159 12.4749 2.15307C12.313 1.74835 13.09 1.08462 13.6243 1.05225C13.9642 1.05225 13.9966 1.37602 13.8509 1.66741Z\" fill=\"#00A000\"></path>\n<path d=\"M6.12972 5.87644C5.54693 6.75062 4.76988 7.07439 4.67275 6.6373C4.55943 6.11927 5.57931 4.77562 6.2916 4.72705C6.76107 4.77562 6.38874 5.48791 6.12972 5.87644Z\" fill=\"#00A000\"></path>\n<path d=\"M23.3061 3.67478C23.5165 3.93379 23.7594 4.45183 23.2413 4.4842C22.3348 4.40326 21.4282 3.0758 21.7196 2.80059C21.7682 2.75203 21.8329 2.75203 21.8977 2.73584C22.351 2.76822 22.9661 3.23768 23.3061 3.67478Z\" fill=\"#00A000\"></path>\n<path d=\"M2.97199 9.87496C2.92343 9.98828 2.51871 10.9596 2.00068 11.0082C1.33695 10.911 2.00068 9.01696 2.69679 8.56368C2.81011 8.48274 2.87486 8.48274 2.93962 8.46655C3.34433 8.53131 3.18244 9.34073 2.97199 9.87496Z\" fill=\"#00A000\"></path>\n<path d=\"M30.3314 11.7206C30.4124 12.1253 30.4448 12.8861 30.0401 12.9347C29.2792 12.8376 28.8421 10.7007 29.2792 10.3284C29.3278 10.2798 29.3925 10.2798 29.4249 10.2798C29.862 10.3445 30.2181 11.154 30.3314 11.7206Z\" fill=\"#00A000\"></path>\n<path d=\"M2.47043 21.7897C2.66469 22.421 2.63231 23.0362 2.27616 22.8743C1.61243 22.5829 0.916326 20.5432 1.43436 20.3975H1.48293C1.88764 20.446 2.30854 21.2393 2.47043 21.7897Z\" fill=\"#00A000\"></path>\n<path d=\"M28.3552 23.8296C27.9343 24.5581 27.2705 25.0923 27.141 24.6714C26.9629 24.121 27.8209 22.5831 28.4523 22.5183C28.8246 22.5669 28.6951 23.2306 28.3552 23.8296Z\" fill=\"#00A000\"></path>\n<path d=\"M10.1606 29.544C10.4035 29.8031 10.5977 30.1268 10.3225 30.1268C9.7883 30.143 8.37989 29.1555 8.63891 28.7994C8.67129 28.7508 8.73604 28.7346 8.8008 28.7346C9.31883 28.767 9.9178 29.285 10.1606 29.544Z\" fill=\"#00A000\"></path>\n<path d=\"M24.9563 27.4396C24.7296 27.6987 24.1792 28.1681 23.7583 28.2005C23.305 28.1519 23.9202 27.213 24.5192 26.7435C24.9239 26.4198 25.1505 26.4036 25.2315 26.4036C25.62 26.4521 25.3933 26.9702 24.9563 27.4396Z\" fill=\"#00A000\"></path>\n<path d=\"M13.1878 30.6613C13.2849 30.7746 13.5115 31.0498 13.2525 31.0822C12.7183 31.0822 11.6822 30.4346 11.9413 30.1756C11.9898 30.127 12.0708 30.1108 12.1193 30.1108C12.5564 30.1108 13.0097 30.467 13.1878 30.6613Z\" fill=\"#00A000\"></path>\n<path d=\"M17.7192 30.7906C17.5735 30.9201 17.2497 31.1305 16.9745 31.1467C16.6346 31.1305 16.8612 30.661 17.1202 30.4344C17.2983 30.2887 17.4764 30.2078 17.6868 30.2078C18.0592 30.2401 17.9944 30.5315 17.7192 30.7906Z\" fill=\"#00A000\"></path>\n<path d=\"M9.64113 2.73581C9.544 2.83294 8.99359 3.35097 8.52412 3.38335C8.16798 3.35097 8.39462 2.94626 8.81552 2.59011C9.04216 2.39585 9.56019 2.02351 9.93253 2.00732C10.3211 2.0397 9.67351 2.70343 9.64113 2.73581Z\" fill=\"#00A000\"></path>\n<path d=\"M16.9275 0.890291C17.0894 1.23025 16.7332 1.40832 16.3933 1.27882C15.94 1.10074 15.9076 0.598897 16.1666 0.469389C16.2152 0.4532 16.2476 0.437012 16.2961 0.437012C16.5552 0.4532 16.8304 0.67984 16.9275 0.890291Z\" fill=\"#00A000\"></path>\n<path d=\"M26.6083 5.5365C26.9644 6.03834 26.9806 6.42687 26.6407 6.3783C26.0741 6.29736 25.0056 4.88896 25.2808 4.59756C25.3132 4.56519 25.3618 4.56519 25.3941 4.56519C25.7989 4.59756 26.3493 5.14797 26.6083 5.5365Z\" fill=\"#00A000\"></path>\n<path d=\"M0.689784 14.2135C0.641218 14.6182 0.51171 15.3143 0.252693 15.3629C-0.232963 15.2658 0.0746191 13.1127 0.39839 12.9023L0.463144 12.8699C0.738349 12.9184 0.754538 13.7279 0.689784 14.2135Z\" fill=\"#00A000\"></path>\n<path d=\"M30.816 19.4909C30.6217 20.2517 30.2656 20.7374 30.1037 20.446C29.877 19.9927 30.2656 18.2767 30.7189 18.1958C30.9779 18.2444 30.9617 18.9081 30.816 19.4909Z\" fill=\"#00A000\"></path>\n<path d=\"M6.7129 27.6823C7.02048 28.0384 7.21474 28.3784 6.93954 28.346C6.38913 28.2651 5.17499 27.0024 5.46638 26.8243L5.54732 26.8081C5.91966 26.8567 6.45388 27.3747 6.7129 27.6823Z\" fill=\"#00A000\"></path>\n<path d=\"M21.0704 29.8516C20.6171 30.1592 20.002 30.402 20.002 30.2239C20.0181 30.0458 20.8923 29.2526 21.4427 29.2202C21.7179 29.2526 21.4751 29.5278 21.2808 29.6897C21.2485 29.7059 21.1675 29.7868 21.0704 29.8516Z\" fill=\"#00A000\"></path>\n<path d=\"M15.2925 31.163C15.3735 31.3249 15.3249 31.4544 14.9849 31.3573C14.6612 31.2601 14.4993 31.0497 14.6612 30.9525L14.7583 30.9202C15.0173 30.8716 15.2116 31.0173 15.2925 31.163Z\" fill=\"#00A000\"></path>\n<path d=\"M12.8303 0.469616C12.3932 0.744822 12.0695 0.809576 12.1018 0.712445C12.1342 0.534371 12.9113 0.194411 13.1541 0.178223C13.1865 0.178223 13.235 0.178223 13.1217 0.275354C13.057 0.32392 12.9436 0.404862 12.8303 0.469616Z\" fill=\"#00A000\"></path>\n<path d=\"M15.3237 0.161885C15.2913 0.22664 15.178 0.339959 14.9999 0.356148C14.8542 0.339959 14.8704 0.242828 14.9676 0.145697C15.0485 0.0809427 15.1942 0 15.2913 0C15.4208 0.0161885 15.3237 0.161885 15.3237 0.161885Z\" fill=\"#00A000\"></path>\n<path d=\"M0.608603 18.9245C0.721923 19.4587 0.721923 19.8148 0.64098 19.7663C0.430529 19.653 0.0743813 17.8884 0.236267 17.8398C0.333398 17.8884 0.495283 18.4226 0.608603 18.9245Z\" fill=\"#00A000\"></path>\n<path d=\"M29.3427 7.9001C29.537 8.24006 29.6503 8.58002 29.4884 8.53145C29.2132 8.45051 28.4847 7.20399 28.679 7.12305H28.6952C28.8571 7.17161 29.1485 7.56014 29.3427 7.9001Z\" fill=\"#00A000\"></path>\n<path d=\"M3.61909 25.3512C3.66766 25.4159 4.03999 25.934 3.92667 25.9663C3.66766 25.9178 2.68015 24.6389 2.84204 24.5417H2.85823C3.00392 24.5903 3.40864 25.0598 3.61909 25.3512Z\" fill=\"#00A000\"></path>\n<path d=\"M18.1414 0.259053C18.3519 0.339996 18.449 0.40475 18.4166 0.420939C18.3357 0.485693 17.4939 0.194299 17.4453 0.113357L17.4615 0.097168C17.5748 0.113357 17.8986 0.178111 18.1414 0.259053Z\" fill=\"#00A000\"></path>\n<path d=\"M2.43813 7.4629C2.35719 7.57622 2.11436 7.96474 2.01723 8.01331C1.87153 7.96474 2.60002 6.88011 2.71334 6.83154H2.72952C2.81047 6.86392 2.4867 7.39814 2.43813 7.4629Z\" fill=\"#00A000\"></path>\n<path d=\"M5.67515 3.78798C5.319 4.12794 5.09236 4.25745 5.07617 4.1765C5.07617 4.03081 5.82084 3.31851 6.06367 3.28613C6.17699 3.28613 5.90179 3.57753 5.67515 3.78798Z\" fill=\"#00A000\"></path>\n<path d=\"M21.0058 1.03617C21.2648 1.18187 21.3944 1.29519 21.3134 1.31138C21.1515 1.34376 20.0993 0.777157 20.1802 0.712402H20.2126C20.3745 0.728591 20.763 0.890476 21.0058 1.03617Z\" fill=\"#00A000\"></path>\n<path d=\"M24.6005 2.81684C24.8919 3.04348 25.0376 3.22156 24.9243 3.22156C24.7139 3.23775 23.4835 2.33119 23.613 2.25024H23.6454C23.8721 2.29881 24.3091 2.5902 24.6005 2.81684Z\" fill=\"#00A000\"></path>\n<path d=\"M9.69156 1.31126C9.57824 1.37602 9.23828 1.55409 9.18971 1.52171C9.17352 1.42458 9.9182 1.06843 10.0801 1.05225C10.0963 1.10081 9.75631 1.27889 9.69156 1.31126Z\" fill=\"#00A000\"></path>\n</svg>\n<img src=\"https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif\"/>\n</div>\n<div>\n<label>\n<span></span>\n</label>\n<h3></h3>\n<div></div>\n<div>\n<form method=\"post\">\n<input type=\"hidden\" value=\"\"/>\n<input type=\"hidden\" value=\"\"/>\n<input type=\"hidden\" value=\"\"/>\n<input type=\"hidden\" value=\"free\"/>\n<input placeholder=\"Email Address\" required=\"\" type=\"email\" value=\"\"/>\n<button>Submit</button>\n</form>\n</div>\n</div>\n</div>\n</div>\n<div>\n<hr/>\n<p>Article printed from InvestorPlace Media, https://investorplace.com/hypergrowthinvesting/2023/08/ai-meets-biotech-transforming-the-drug-development-process/.</p>\n<p>©2023 InvestorPlace Media, LLC</p>\n</div>\n<div></div>\n</div></body></html>","source":"investorplace_stock_picks","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia Just Confirmed an Emerging AI Boom in Biotech</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia Just Confirmed an Emerging AI Boom in Biotech\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-08-07 22:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/hypergrowthinvesting/2023/08/ai-meets-biotech-transforming-the-drug-development-process/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Trillion-dollar AI chipmaker Nvidia recently announced a huge new partnership with biotech AI startup Recursion Pharmaceuticals.AI’s application in the field of biology holds the potential to unlock ...</p>\n\n<a href=\"https://investorplace.com/hypergrowthinvesting/2023/08/ai-meets-biotech-transforming-the-drug-development-process/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4141":"半导体产品","BK4122":"互联网与直销零售","BK4503":"景林资产持仓","BK4551":"寇图资本持仓","LU0289739343.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (SGD) ACC","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","LU0348723411.USD":"ALLIANZ GLOBAL HI-TECH GROWTH \"A\" (USD) INC","BK4561":"索罗斯持仓","LU1829250122.USD":"高盛欧洲核心股票组合Acc","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","BK4505":"高瓴资本持仓","IE00BFSS7M15.SGD":"Janus Henderson Balanced A Acc SGD-H","LU1267930730.SGD":"富兰克林美国机遇基金AS Acc SGD (CPF)","LU0234570918.USD":"高盛全球核心股票组合Acc Close","LU0238689110.USD":"贝莱德环球动力股票基金","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","LU0642271901.SGD":"Janus Henderson Horizon Global Technology Leaders A2 SGD-H","LU0053666078.USD":"摩根大通基金-美国股票A（离岸）美元","LU0072462426.USD":"贝莱德全球配置 A2","BK4529":"IDC概念","LU0056508442.USD":"贝莱德世界科技基金A2","AMZN":"亚马逊","LU0080751232.USD":"富达环球多元动力基金A","BK4568":"美国抗疫概念","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","LU0308772762.SGD":"Blackrock Global Allocation A2 SGD-H","IE00BMPRXR70.SGD":"Neuberger Berman 5G Connectivity A Acc SGD-H","IE00BMPRXN33.USD":"NEUBERGER BERMAN 5G CONNECTIVITY \"A\" (USD) ACC","RXRX":"Recursion Pharmaceuticals, Inc.","AZN":"阿斯利康","LU0234572021.USD":"高盛美国核心股票组合Acc","AAPL":"苹果","NVDA":"英伟达","LU0353189763.USD":"ALLSPRING  US ALL CAP GROWTH FUND \"I\" (USD) ACC","LU1064131342.USD":"Fullerton Lux Funds - Global Absolute Alpha A Acc USD","BK4507":"流媒体概念","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","BK4139":"生物科技","BK4566":"资本集团","IE00BWXC8680.SGD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A5\" (SGD) ACC","LU0979878070.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"A\" (USD) ACC","LU0320765059.SGD":"FTIF - Franklin US Opportunities A Acc SGD","BK4524":"宅经济概念","SNY":"赛诺菲安万特","LU0672654240.SGD":"FTIF - Franklin US Opportunities A Acc SGD-H1","IE00BD6J9T35.USD":"NEUBERGER BERMAN NEXT GENERATION MOBILITY \"A\" (USD) ACC","BK4501":"段永平概念","BK4527":"明星科技股","LU0786609619.USD":"高盛全球千禧一代股票组合Acc"},"source_url":"https://investorplace.com/hypergrowthinvesting/2023/08/ai-meets-biotech-transforming-the-drug-development-process/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2357588012","content_text":"Trillion-dollar AI chipmaker Nvidia recently announced a huge new partnership with biotech AI startup Recursion Pharmaceuticals.AI’s application in the field of biology holds the potential to unlock enormous economic value for one simple reason: data.The drug discovery and development process is prohibitively long and expensive, but AI can significantly shorten and cheapen this process. It can map out human genetic data, identify mutations, and run simulations of compounds to fight those mutations – all in an instant.Earlier this year, Japanese pharma giant Takeda Pharmaceutical bought an experimental psoriasis drug for $4 billion – a drug that was created in only six months by using AI. And it isn’t alone. \n\n\n\n \n\nSource: shutterstock.com/cono0430\n\n\n\nEditor’s note: “Nvidia Just Confirmed an Emerging AI Boom in Biotech” was previously published in July 2023. It has since been updated to include the most relevant information available.\nWe’ve long said that artificial intelligence (AI) will have the most profound economic impact in the medical industry, where it can be used to accelerate and cheapen everything from drug discovery to patient treatment.\nAnd Nvidia (NVDA), the world’s preeminent AI company, may have just confirmed that sentiment last month.\nThe trillion-dollar AI chipmaker announced a huge new partnership with biotech AI startup Recursion Pharmaceuticals (RXRX), which has developed a novel AI-driven platform for drug development and discovery.\nRecursion will train its AI models on Nvidia’s cloud platform, which Nvidia will then license through its newly announced BioNeMo generative AI cloud service for drug discovery.\nNvidia will also pour $50 million into Recursion in exchange for a ~4% stake in the company.\nThis is a massive deal. Look no further than how much RXRX stock rallied before and after the deal was announced.\n\nBut this is likely just the start of the big boom at the convergence of AI and medicine. \nNvidia is a trillion-dollar juggernaut in the world of AI. It could’ve chosen any industry to commit its money and resources to. And of all industries, it chose biotechnology.\nWhy?\nData.\n\n\n\n\n\n\nIn a World of Data, Today’s AI Is Just the Beginning\nLike computers, humans are nothing more than a bunch of data strung together. \nAt their core, computers are just a bunch of 1s and 0s coded in sequence, with each number corresponding to a certain action for the computer to perform. Human DNA is much the same. We’re just a bunch of As, Gs, Cs, and Ts strung together. Those are the four base types found in human DNA molecules, each determining a person’s characteristics, traits, and even actions. \n\nEssentially, the connecting element here is data. \nThat means AI can have an especially profound impact on the human body. \nAfter all, at the end of the day, what is AI? It is just a machine learning algorithm processing tons of data to learn how to perform a certain task or variety of tasks. It’s all just algorithms and data, with data acting as the model’s “fuel.”\nThe quantity and quality of data an AI model has access to determines the quality of the model itself. \nWhen it comes to the human body, there is no dearth of quality data. As mentioned above, we are nothing more than a bunch of quality genetic data strung together.\nApply AI to all that data, and you will change the world. \nSeriously. \nConsider the value proposition of Recursion’s core AI technology.\nCurrently, it takes about $900 million and 13.5 years to develop a new successful drug. With AI constantly running simulations, drug development could happen in months and for less than $100 million.\nThat may sound hard to believe, but it’s true. Drugs are already being discovered by AI that quickly. \nAI Meets Biotech\nEarlier this year, Japanese pharma giant Takeda Pharmaceutical bought an experimental psoriasis drug for $4 billion – a drug that was created in only six months by using artificial intelligence. \nAnd it isn’t alone. \nOther pharma giants like Bayer (BAYRY), Roche (RHHBY), Sanofi (SNY), and AstraZeneca (AZN) are actively using AI technology for drug discovery purposes. \nThe future of drug discovery starts now. \nThis is big business. \nResearch firm Deep Pharma Intelligence estimates that investments in the field of AI-powered drug discovery have tripled over the past four years to nearly $25 billion. Morgan Stanley believes that AI-powered drug discovery will lead to an additional 50 novel therapies being brought to market over the next decade, with annual sales in excess of $50 billion!\nSource: Deep Pharma Intelligence\nIn other words, a $50 billion drug discovery revolution starts now. \nIs your portfolio positioned for it?\n\n\n\n\n\n\nThe Final Word\nIf not, I want to tell you about one of my favorite investments for this new bull market. \nOne great prospective investment is the very company that started this whole stock boom – OpenAI, the creator of ChatGPT. \nSince ChatGPT’s launch in November 2022, the company’s valuation has doubled!\nBut that’s just the start. \nI truly believe OpenAI could be one of the world’s largest companies in the near future – if not the largest. \nOpenAI represents the potential investment opportunity of a lifetime. \nToo bad it is a startup that you can’t buy on a public exchange like a big stock… \nThough I did manage to unearth an investment ‘loophole’ that allows you to take a stake in OpenAI now – before its highly anticipated IPO. \nThis is your chance to invest in the next big thing. Like investing in Apple (AAPL) in the 1980s or Amazon (AMZN) in the 1990s, this is an opportunity you can’t afford to miss. \nLearn all about it.\nOn the date of publication, Luke Lango did not have (either directly or indirectly) any positions in the securities mentioned in this article.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nSubmit\n\n\n\n\n\n\n\nArticle printed from InvestorPlace Media, https://investorplace.com/hypergrowthinvesting/2023/08/ai-meets-biotech-transforming-the-drug-development-process/.\n©2023 InvestorPlace Media, LLC","news_type":1},"isVote":1,"tweetType":1,"viewCount":151,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":204977863131360,"gmtCreate":1691052799092,"gmtModify":1691052812946,"author":{"id":"4103671026890570","authorId":"4103671026890570","name":"QueenSW","avatar":"https://community-static.tradeup.com/news/aa7c7803f7160b36b43cdc1267474765","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4103671026890570","authorIdStr":"4103671026890570"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NIO\">$NIO Inc.(NIO)$ &nbsp;</a>I'm still waiting for $21","listText":"<a href=\"https://ttm.financial/S/NIO\">$NIO Inc.(NIO)$ &nbsp;</a>I'm still waiting for $21","text":"$NIO Inc.(NIO)$ I'm still waiting for $21","images":[{"img":"https://community-static.tradeup.com/news/2241a9b428aeb7a8bfd0fc81ea885493","width":"1080","height":"1756"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/204977863131360","isVote":1,"tweetType":1,"viewCount":161,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":203004370411608,"gmtCreate":1690590767604,"gmtModify":1690590771240,"author":{"id":"4103671026890570","authorId":"4103671026890570","name":"QueenSW","avatar":"https://community-static.tradeup.com/news/aa7c7803f7160b36b43cdc1267474765","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4103671026890570","authorIdStr":"4103671026890570"},"themes":[],"htmlText":"Fantastic!!! Finally. A long awaited. Can we see 150 before mid Aug?&nbsp;","listText":"Fantastic!!! Finally. A long awaited. Can we see 150 before mid Aug?&nbsp;","text":"Fantastic!!! Finally. A long awaited. Can we see 150 before mid Aug?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/203004370411608","repostId":"1166658010","repostType":2,"repost":{"id":"1166658010","kind":"news","pubTimestamp":1690589898,"share":"https://ttm.financial/m/news/1166658010?lang=&edition=fundamental","pubTime":"2023-07-29 08:18","market":"us","language":"en","title":"Roku Delivers A Beat For The Ages, This Rally Is For Real","url":"https://stock-news.laohu8.com/highlight/detail?id=1166658010","media":"Seeking Alpha","summary":"SummaryRoku stock surged 25% on Friday after releasing strong earnings.The company handily beat guidance as the ad recovery is underway.The company has a $1.8 billion net cash balance sheet position.T","content":"<html><head></head><body><h2 id=\"id_2663137842\" style=\"text-align: left;\">Summary</h2><ul><li><p>Roku stock surged 31% on Friday after releasing strong earnings.</p></li><li><p>The company handily beat guidance as the ad recovery is underway.</p></li><li><p>The company has a $1.8 billion net cash balance sheet position.</p></li><li><p>The stock is still trading at a reasonable 8x gross profits even after the rally - I reiterate my buy rating.</p></li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/35e4bd6b2e2e40eab1ddb2ae365010e1\" title=\"Phillip Faraone/Getty Images Entertainment\" tg-width=\"750\" tg-height=\"500\"/><span>Phillip Faraone/Getty Images Entertainment</span></p><p style=\"text-align: left;\">Roku (NASDAQ:ROKU) stock surged on Friday after unveiling earnings results which blew away guidance. If Nvidia (NVDA) delivered “guidance for the ages” earlier this year, then ROKU delivered a “beat for the ages.” OK, I exaggerate a bit. Like other advertising giants that reported before it, ROKU showed that the advertising recovery was underway, with solid YOY revenue growth. But ROKU was also able to deliver a surprise profit beat. These strong results increase investor confidence in management’s ability to deliver against their commitment of positive adjusted EBITDA by 2024, which may be explaining in part the strong stock rally today. I reiterate my buy rating for the stock as the stars are beginning to align here.</p><h2 id=\"id_331642373\" style=\"text-align: left;\">ROKU Stock Price</h2><p style=\"text-align: left;\">While ROKU remains far below all-time highs, the stock is now trading near 52-week highs. This rally is for real.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9fad766a7b9952001a5fabd5e70c3e6f\" title=\"Data by YCharts\" tg-width=\"635\" tg-height=\"417\"/><span>Data by YCharts</span></p><p style=\"text-align: left;\">I last covered ROKU in April, where I rated the stock a buy but explained why investors (perhaps just yours truly) were growing impatient on the growth story. My impatience proved unwarranted, as ROKU has turned things around.</p><h2 id=\"id_861898590\" style=\"text-align: left;\">ROKU Stock Key Metrics</h2><p style=\"text-align: left;\">This past quarter saw ROKU continue to take market share in TV viewing, with active accounts growing 16% YOY and streaming hours growing 21% YOY. It pays to be the top selling TV operating system in the country. Average revenue per user (&#39;ARPU&#39;) declined 7% YOY but that is not too surprising given the tough economy as well as the fact that new users inherently have lower monetization rates to begin with.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8fdf09d49608a72b696caf2ea885546d\" title=\"2023 Q2 Shareholder Letter\" tg-width=\"665\" tg-height=\"96\"/><span>2023 Q2 Shareholder Letter</span></p><p style=\"text-align: left;\">It is curious that The Roku Channel represented 1.1% of all TV viewing (ROKU notes that a large portion of the other streaming hours are done on their platform).</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a054f680d0113edf9b975df7f6109bf4\" title=\"2023 Q2 Shareholder Letter\" tg-width=\"724\" tg-height=\"398\"/><span>2023 Q2 Shareholder Letter</span></p><p style=\"text-align: left;\">ROKU delivered 11% YOY revenue growth to $847.2 million, blowing past guidance for $770 million. Gross profits came in at $378.3 million (ahead of $335 million guidance) and the adjusted EBITDA loss came in at $17.8 million (ahead of $75 million guidance). I can say that this beat came as a surprise as I am doubtful that investors were expecting the recovery to happen so swiftly as it has here.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/878c15f915b78a977b28199cc8350d3d\" title=\"2023 Q2 Shareholder Letter\" tg-width=\"706\" tg-height=\"364\"/><span>2023 Q2 Shareholder Letter</span></p><p style=\"text-align: left;\">ROKU ended the quarter with $1.8 billion of cash versus no debt. Looking forward, ROKU has guided for $815 million in net revenue in the third quarter, representing 7% YOY growth but a sequential decline. That reflects some impact from the ongoing writers’ strike. Gross profits are expected to come in at $355 million, roughly flat YOY and the adjusted EBITDA loss is expected to widen to $50 million. It appears that investors are looking past the expected reversal of fortunes.</p><p style=\"text-align: left;\">On the conference call, management reiterated expectations for positive adjusted EBITDA for the full year 2024 and guided for device gross margin to improve to the “negative low teens.” I note that despite the stock price reaction today, management cannot be blamed for being promotional. An analyst asked why management described their 11% revenue growth as being modest, asking “what’s normal,” but management clarified that they are “very happy with” their results. The tough macro environment has not completely subsided, but ROKU appears to have turned the corner here.</p><h2 id=\"id_2144212158\" style=\"text-align: left;\">Is ROKU Stock A Buy, Sell, or Hold?</h2><p style=\"text-align: left;\">ROKU finds itself in an enviable position of benefitting from both the shift towards smart TVs as well as the growth of video streaming.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b55429b80fdecb1df6bc05237400a248\" title=\"2023 Q2 Shareholder Letter\" tg-width=\"803\" tg-height=\"468\"/><span>2023 Q2 Shareholder Letter</span></p><p style=\"text-align: left;\">Growth in these segments has been difficult following the pandemic due to tough comparables and a tough economy, but the long term outlook remains bright as I find it difficult to imagine these tailwinds reversing. After today’s rally, the stock traded at around 8x gross profits, which is a reasonable valuation given consensus estimates for double-digit top-line growth in the years to come.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e2804013327665d2a5f475a861bb656a\" title=\"Seeking Alpha\" tg-width=\"970\" tg-height=\"176\"/><span>Seeking Alpha</span></p><p style=\"text-align: left;\">Based on 13% projected growth, a 50% net margin (based on gross profits), and a 1.5x price to earnings growth ratio (‘PEG ratio’), I could see ROKU trading at around 10x gross profits, representing ample upside from both multiple expansion and projected growth.</p><p style=\"text-align: left;\">What are the key risks? As management stated, “advertising is cyclical” and it has been curious to witness ROKU undergo such dramatic shifts in profitability over the past several years. It is possible that growth slows down moving forward, perhaps due to unforeseen competition. I am of the view that ROKU may be better off focusing on its smart TV business instead of its own streaming ambitions as I question the long term economic benefit there. It is possible that management invests even heavier in streaming, or that their heavy investment is indicative of their view that competitive threats may impede their smart TV growth thesis.</p><p style=\"text-align: left;\">I reiterate my buy rating due to the strong net cash balance sheet, reasonable valuation, and evidence of a fundamental turnaround.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Roku Delivers A Beat For The Ages, This Rally Is For Real</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoku Delivers A Beat For The Ages, This Rally Is For Real\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-07-29 08:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4621152-roku-delivers-a-beat-for-the-ages-this-rally-is-for-real><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryRoku stock surged 31% on Friday after releasing strong earnings.The company handily beat guidance as the ad recovery is underway.The company has a $1.8 billion net cash balance sheet position....</p>\n\n<a href=\"https://seekingalpha.com/article/4621152-roku-delivers-a-beat-for-the-ages-this-rally-is-for-real\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ROKU":"Roku Inc"},"source_url":"https://seekingalpha.com/article/4621152-roku-delivers-a-beat-for-the-ages-this-rally-is-for-real","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1166658010","content_text":"SummaryRoku stock surged 31% on Friday after releasing strong earnings.The company handily beat guidance as the ad recovery is underway.The company has a $1.8 billion net cash balance sheet position.The stock is still trading at a reasonable 8x gross profits even after the rally - I reiterate my buy rating.Phillip Faraone/Getty Images EntertainmentRoku (NASDAQ:ROKU) stock surged on Friday after unveiling earnings results which blew away guidance. If Nvidia (NVDA) delivered “guidance for the ages” earlier this year, then ROKU delivered a “beat for the ages.” OK, I exaggerate a bit. Like other advertising giants that reported before it, ROKU showed that the advertising recovery was underway, with solid YOY revenue growth. But ROKU was also able to deliver a surprise profit beat. These strong results increase investor confidence in management’s ability to deliver against their commitment of positive adjusted EBITDA by 2024, which may be explaining in part the strong stock rally today. I reiterate my buy rating for the stock as the stars are beginning to align here.ROKU Stock PriceWhile ROKU remains far below all-time highs, the stock is now trading near 52-week highs. This rally is for real.Data by YChartsI last covered ROKU in April, where I rated the stock a buy but explained why investors (perhaps just yours truly) were growing impatient on the growth story. My impatience proved unwarranted, as ROKU has turned things around.ROKU Stock Key MetricsThis past quarter saw ROKU continue to take market share in TV viewing, with active accounts growing 16% YOY and streaming hours growing 21% YOY. It pays to be the top selling TV operating system in the country. Average revenue per user ('ARPU') declined 7% YOY but that is not too surprising given the tough economy as well as the fact that new users inherently have lower monetization rates to begin with.2023 Q2 Shareholder LetterIt is curious that The Roku Channel represented 1.1% of all TV viewing (ROKU notes that a large portion of the other streaming hours are done on their platform).2023 Q2 Shareholder LetterROKU delivered 11% YOY revenue growth to $847.2 million, blowing past guidance for $770 million. Gross profits came in at $378.3 million (ahead of $335 million guidance) and the adjusted EBITDA loss came in at $17.8 million (ahead of $75 million guidance). I can say that this beat came as a surprise as I am doubtful that investors were expecting the recovery to happen so swiftly as it has here.2023 Q2 Shareholder LetterROKU ended the quarter with $1.8 billion of cash versus no debt. Looking forward, ROKU has guided for $815 million in net revenue in the third quarter, representing 7% YOY growth but a sequential decline. That reflects some impact from the ongoing writers’ strike. Gross profits are expected to come in at $355 million, roughly flat YOY and the adjusted EBITDA loss is expected to widen to $50 million. It appears that investors are looking past the expected reversal of fortunes.On the conference call, management reiterated expectations for positive adjusted EBITDA for the full year 2024 and guided for device gross margin to improve to the “negative low teens.” I note that despite the stock price reaction today, management cannot be blamed for being promotional. An analyst asked why management described their 11% revenue growth as being modest, asking “what’s normal,” but management clarified that they are “very happy with” their results. The tough macro environment has not completely subsided, but ROKU appears to have turned the corner here.Is ROKU Stock A Buy, Sell, or Hold?ROKU finds itself in an enviable position of benefitting from both the shift towards smart TVs as well as the growth of video streaming.2023 Q2 Shareholder LetterGrowth in these segments has been difficult following the pandemic due to tough comparables and a tough economy, but the long term outlook remains bright as I find it difficult to imagine these tailwinds reversing. After today’s rally, the stock traded at around 8x gross profits, which is a reasonable valuation given consensus estimates for double-digit top-line growth in the years to come.Seeking AlphaBased on 13% projected growth, a 50% net margin (based on gross profits), and a 1.5x price to earnings growth ratio (‘PEG ratio’), I could see ROKU trading at around 10x gross profits, representing ample upside from both multiple expansion and projected growth.What are the key risks? As management stated, “advertising is cyclical” and it has been curious to witness ROKU undergo such dramatic shifts in profitability over the past several years. It is possible that growth slows down moving forward, perhaps due to unforeseen competition. I am of the view that ROKU may be better off focusing on its smart TV business instead of its own streaming ambitions as I question the long term economic benefit there. It is possible that management invests even heavier in streaming, or that their heavy investment is indicative of their view that competitive threats may impede their smart TV growth thesis.I reiterate my buy rating due to the strong net cash balance sheet, reasonable valuation, and evidence of a fundamental turnaround.","news_type":1},"isVote":1,"tweetType":1,"viewCount":291,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"following","isTTM":true}